Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jenna L. Jeffrey
Observed names:
J. Jeffrey,
J.L. Jeffrey,
Jeffrey, J.L.,
Jeffrey, Jenna L.,
Jenna Jeffrey
Institution:
Arcus Biosciences (United States)
Observed institutions:
University of Oregon,
Princeton University,
Arcus Biosciences (United States),
University of California, Berkeley
ORCID:
0000-0001-9249-5984
Observed ORCID:
0000-0001-9249-5984
OpenAlex ID:
A5084888956
Works
54
Awards
1
O–H hydrogen bonding promotes H-atom transfer from α C–H bonds for C-alkylation of alcohols
2015
·
Jenna L. Jeffrey
, Jack A. Terrett
, et al.
·
Science
·
607
Intramolecular C(sp 3 )–H amination
2013
·
Jenna L. Jeffrey
, Richmond Sarpong
·
Chemical Science
·
332
Selective Radical–Radical Cross-Couplings: Design of a Formal β-Mannich Reaction
2015
·
Jenna L. Jeffrey
, Filip R. Petronijević
, et al.
·
Journal of the American Chemical Society
·
257
Concise Synthesis of Pauciflorol F Using a Larock Annulation
2009
·
Jenna L. Jeffrey
, Richmond Sarpong
·
Organic Letters
·
136
Discovery of AB680: A Potent and Selective Inhibitor of CD73
2020
·
Kenneth V. Lawson
, Jaroslaw Kalisiak
, et al.
·
Journal of Medicinal Chemistry
·
100
Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39
2020
·
Jenna L. Jeffrey
, Kenneth V. Lawson
, et al.
·
Journal of Medicinal Chemistry
·
91
Photoredox-catalyzed deoxyfluorination of activated alcohols with Selectfluor®
2019
·
María González-Esguevillas
, Javier Miró
, et al.
·
Tetrahedron
·
72
Discovery of Potent and Selective Non-Nucleotide Small Molecule Inhibitors of CD73
2020
·
Joel W. Beatty
, Erick A. Lindsey
, et al.
·
Journal of Medicinal Chemistry
·
68
An approach to the synthesis of dimeric resveratrol natural products via a palladium-catalyzed domino reaction
2009
·
Jenna L. Jeffrey
, Richmond Sarpong
·
Tetrahedron Letters
·
68
Safety, tolerability, and pharmacology of AB928, a novel dual adenosine receptor antagonist, in a randomized, phase 1 study in healthy volunteers
2018
·
Lisa Seitz
, Lixia Jin
, et al.
·
Investigational New Drugs
·
67
Discovery of Potent and Selective PI3Kγ Inhibitors
2020
·
Samuel L. Drew
, Rhiannon Thomas-Tran
, et al.
·
Journal of Medicinal Chemistry
·
46
PDF
Intramolecular C(sp3)N Coupling by Oxidation of Benzylic C,N‐Dianions
2013
·
Jenna L. Jeffrey
, Emily S. Bartlett
, et al.
·
Angewandte Chemie International Edition
·
46
Chichibabin-Type Direct Alkylation of Pyridyl Alcohols with Alkyl Lithium Reagents
2012
·
Jenna L. Jeffrey
, Richmond Sarpong
·
Organic Letters
·
35
Discovery of Potent and Selective 7-Azaindole Isoindolinone-Based PI3Kγ Inhibitors
2020
·
Dillon H. Miles
, Xuelei Yan
, et al.
·
ACS Medicinal Chemistry Letters
·
24
Design, Synthesis, and Structure–Activity Relationship Optimization of Pyrazolopyrimidine Amide Inhibitors of Phosphoinositide 3-Kinase γ (PI3Kγ)
2021
·
Guillaume Mata
, Dillon H. Miles
, et al.
·
Journal of Medicinal Chemistry
·
19
Synthesis of 1-Substituted Benzo[c]isoxazol-3(1H)-imines via Tandem Nitroso-Ene/Intramolecular Cyclizations of 2-Nitrosobenzonitrile
2008
·
Jenna L. Jeffrey
, Sean P. McClintock
, et al.
·
The Journal of Organic Chemistry
·
14
Abstract A162: AB928, a dual antagonist of the A2aR and A2bR adenosine receptors, relieves adenosine-mediated immune suppression
2019
·
Daniel DiRenzo
, Dana Piovesan
, et al.
·
Cancer Immunology Research
·
12
Development of a Robust and Scalable Synthetic Route for a Potent and Selective Isoindolinone PI3Kγ Inhibitor
2022
·
Artur K. Mailyan
, Guillaume Mata
, et al.
·
Organic Process Research & Development
·
9
Development of a Scalable and Practical Synthesis of AB928, a Dual A2a/A2b Receptor Antagonist
2020
·
Ehesan U. Sharif
, Dillon H. Miles
, et al.
·
Organic Process Research & Development
·
9
Intramolecular C(sp3)N Coupling by Oxidation of Benzylic C,N‐Dianions
2013
·
Jenna L. Jeffrey
, Emily S. Bartlett
, et al.
·
Angewandte Chemie
·
9
Abstract 1756: Discovery and characterization of AB680, a potent and selective small-molecule CD73 inhibitor for cancer immunotherapy
2018
·
Kenneth V. Lawson
, Lixia Jin
, et al.
·
Cancer Research
·
6
Abstract 710: CD73 inhibitors (CD73i) reverse the AMP/adenosine-mediated impairment of immune effector cell activation by immune checkpoint inhibitors (ICI)
2018
·
Annette Becker
, Nell Narasappa
, et al.
·
Cancer Research
·
5
Photoredox-catalyzed deoxyfluorination of activated alcohols with Selectfluor®
2023
·
María González-Esguevillas
, Javier Miró
, et al.
·
Tetrahedron
·
4
AB680, a potent and selective CD73 small molecule inhibitor, reverses the AMP/adenosine-mediated impairment of immune effector cell activation by immune checkpoint inhibitors
2018
·
U. Schindler
, A. Becker
, et al.
·
European Journal of Cancer
·
4
Abstract PR001: Discovery of Etrumadenant, a first-in-class dual A2a and A2b adenosine receptor antagonist for cancer immunotherapy
2024
·
Ehesan U. Sharif
, Dillon H. Miles
, et al.
·
Molecular Cancer Therapeutics
·
3
Show more works
View as search
Works count:
54
Citation count:
2,058
H-index:
15
I10-index:
17
Year
Topic
Type